Join the Epilepsy group to help and get support from people like you.
Epilepsy News (Page 4)
FDA Approves Briviact (brivaracetam) to Treat Partial Onset Seizures
February 19, 2016 – The U.S. Food and Drug Administration yesterday approved Briviact (brivaracetam) as an add-on treatment to other medications to treat partial onset seizures in patients age 16...
FDA Approves Spritam (levetiracetam) as the First 3D Printed Drug Product
BLUE ASH, Ohio, August 3, 2015 – Aprecia Pharmaceuticals Company today announced that the U.S. Food and Drug Administration (FDA) has approved Spritam (levetiracetam) for oral use as a prescription...
FDA Approves Fycompa as Adjunctive Treatment for Primary Generalized Tonic-Clonic Seizures
Tokyo, June 22, 2015 – Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. has received approval from the U.S. Food and Drug Administration (FDA) for an indication expansion...
Sun Pharma Announces FDA Approval of Elepsia XR (levetiracetam) Extended-Release Tablets
March 04, 2015, Mumbai: Sun Pharma Advanced Research Company Ltd. (SPARC) today announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Elepsia XR...
FDA Approves Aptiom to Treat Seizures in Adults
November 8, 2013 – The U.S. Food and Drug Administration today approved Aptiom (eslicarbazepine acetate) as an add-on medication to treat seizures associated with epilepsy. Epilepsy is a brain...
FDA Medwatch Alert: Potiga (Ezogabine): Drug Safety Communication - Linked To Retinal Abnormalities And Blue Skin Discoloration
UPDATED 11/01/2013: FDA approved changes to the drug label, underscoring risks of abnormalities to the retina in the eye, potential vision loss, and skin discoloration, all of which may become ...
Supernus Announces Final FDA Approval and Upcoming Launch of Trokendi XR
ROCKVILLE, Md., Aug. 19, 2013 (GLOBE NEWSWIRE) – Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company, received final approval from the Food & Drug Administration (the "FDA") for...
FDA Approves Fycompa (perampanel) to Treat Partial Onset Seizures
October 23, 2012 – The U.S. Food and Drug Administration today approved Fycompa (perampanel) tablets to treat partial onset seizures in patients with epilepsy ages 12 years and older. Partial...
FDA Medwatch Alert: Antiepileptic Drugs
[UPDATE 05/05/2009] FDA notified healthcare professionals that it approved updated labeling for antiepileptic drugs used to treat epilepsy, psychiatric disorders, and other conditions (e.g., migraine...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Seizures, Lennox-Gastaut Syndrome
Related drug support groups
gabapentin, Klonopin, clonazepam, Lyrica, Lamictal, lorazepam, diazepam, Topamax, lamotrigine, view more... pregabalin, Depakote, Neurontin, topiramate, Keppra, Trileptal, Tegretol, oxcarbazepine, phenobarbital, levetiracetam, Vimpat